The present state of the tuberculosis drug development pipeline
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference72 articles.
1. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015;Collaborators GBDT;Lancet Infect Dis,2018
2. The diagnosis and therapy of tuberculosis during the past 100 years;Mitchison;Am J Respir Crit Care Med,2005
3. Development of a Novel Lead that Targets M. tuberculosis polyketide Synthase 13;Aggarwal;Cell,2017
4. Discovery of a potent and specific M. tuberculosis Leucyl-tRNA synthetase inhibitor: (S)-3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656);Li;J Med Chem,2017
5. Discovery of novel oral protein synthesis inhibitors of M. tuberculosis that target leucyl-tRNA synthetase;Palencia;Antimicrob Agents Chemother,2016
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection;2024-09-04
2. α-Aminooxyacetic acid derivatives acting as pro-drugs againstMycobacterium tuberculosis;2024-04-04
3. Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease;Nature Reviews Drug Discovery;2024-02-28
4. Complementary supramolecular drug associates in perfecting the multidrug therapy against multidrug resistant bacteria;Frontiers in Immunology;2024-02-13
5. The quest to deliver high-dose rifampicin: can the inhaled approach help?;Expert Opinion on Drug Delivery;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3